PODXL and neoplasm: The proportion of tumours with high PODXL expression was relatively small compared to the proportion in previous studies (5.7% vs. 7.9–13.4%) ([17,18], which could be explained by differences in antibody, patient series, staining methods, and staining evaluation/cut- off points.